EMPOWER CBD, THE REVERSE GATEWAY DRUG Trademark

Trademark Overview


On Wednesday, July 10, 2019, a trademark application was filed for EMPOWER CBD, THE REVERSE GATEWAY DRUG with the United States Patent and Trademark Office. The USPTO has given the EMPOWER CBD, THE REVERSE GATEWAY DRUG trademark a serial number of 88507839. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Monday, August 26, 2024. This trademark is owned by EmpowerPharm Inc. The EMPOWER CBD, THE REVERSE GATEWAY DRUG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, nonsteroidal anti-inflammatory drugs (NSAIDs), ibuprofen, naproxen sodium, acetaminophen, cold, sore throat and cough medications, guaifenesin, liquid cough medicines with dextromethorphan, decongestant nasal sprays, pseudoephedrine, phenylephrine, allergy medications, antihistamine pills and liquids, diphenhydramine, chlorpheniramine, brompheniramine, loratadine, fexofenadine, cetirizine, stomach upset medications, antidiarrhea medicines, loperamide, bismuth, nausea and vomiting, motion sickness, dimenhydrinate; cannabidiol (CBD) which is synthetically derived with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis in the form of lotions, skin creams for topical medicinal use; creams, ointments, skin patches, extended release tablets and liquids for therapeutic purposes containing cannabidiol (CBD) which is synthetically derived with a delta-9 tetrahydrocannabinol (THC) concentration of not more th...
empower cbd, the reverse gateway drug

General Information


Serial Number88507839
Word MarkEMPOWER CBD, THE REVERSE GATEWAY DRUG
Filing DateWednesday, July 10, 2019
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateMonday, August 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, nonsteroidal anti-inflammatory drugs (NSAIDs), ibuprofen, naproxen sodium, acetaminophen, cold, sore throat and cough medications, guaifenesin, liquid cough medicines with dextromethorphan, decongestant nasal sprays, pseudoephedrine, phenylephrine, allergy medications, antihistamine pills and liquids, diphenhydramine, chlorpheniramine, brompheniramine, loratadine, fexofenadine, cetirizine, stomach upset medications, antidiarrhea medicines, loperamide, bismuth, nausea and vomiting, motion sickness, dimenhydrinate; cannabidiol (CBD) which is synthetically derived with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis in the form of lotions, skin creams for topical medicinal use; creams, ointments, skin patches, extended release tablets and liquids for therapeutic purposes containing cannabidiol (CBD) which is synthetically derived with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Pseudo MarkEMPOWER CANNABIDIOL THE REVERSE GATEWAY DRUG
NOT AVAILABLE"CBD"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 17, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEmpowerPharm Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlington, Ontario L7L6M1
CA

Trademark Events


Event DateEvent Description
Saturday, July 13, 2019NEW APPLICATION ENTERED
Wednesday, July 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, August 4, 2019ASSIGNED TO EXAMINER
Wednesday, April 8, 2020ASSIGNED TO EXAMINER
Tuesday, April 14, 2020NON-FINAL ACTION WRITTEN
Tuesday, April 14, 2020NON-FINAL ACTION E-MAILED
Tuesday, April 14, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 14, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 14, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 10, 2020SUSPENSION LETTER WRITTEN
Tuesday, November 10, 2020LETTER OF SUSPENSION E-MAILED
Tuesday, November 10, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, May 14, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, November 15, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, June 7, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, December 20, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 20, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 4, 2023ASSIGNED TO EXAMINER
Friday, January 6, 2023ASSIGNED TO EXAMINER
Monday, February 6, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, August 24, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 26, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, August 26, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED